United States· US:72789-213_40ac0f51-34ed-e949-e063-6294a90a2366
Abiraterone
A abiraterone product containing abiraterone acetate, registered in United States by PD-Rx Pharmaceuticals, Inc.. The same ATC class is registered in 18 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Abiraterone is registered in 18 of 19 countries.
Countries holding a registration under ATC L02BX03 (abiraterone), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 10 of them publish a price we can compare per daily dose
Abiraterone · ATC L02BX03
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of abiraterone costs, country by country.
Normalised to the WHO defined daily dose (1 g), so markets compare like for like.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Abiraterone · price per daily dose (1 g)
USD · FX 28 Sept 2026
- CH Switzerland$42.72
- FR France$33.07
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ABIRATERONE ACETATE
- Manufacturer
- PD-Rx Pharmaceuticals, Inc.
- Country
- United States (US)
- ATC code
- L02BX03
- ATC class
- Abiraterone
- Defined daily dose
- 1 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc117278921398120 TABLET in 1 BOTTLE, PLASTIC (72789-213-98)
- ndc1172789-213-98
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
461 interactions on record for abiraterone.
Graded by severity as the source publishes them — 101 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Abiraterone · interactions on record
461 records
- 101 severe
- 335 moderate
- 25 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- LoperamideA07DA03severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Abiraterone in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainABIRATERONA ACCORD 250 MG COMPRIMIDOS EFGAccord Healthcare S.L.U.
- CanadaAPO-ABIRATERONE FILM COATED TABLETSAPOTEX INC
- NetherlandsAbirateron betapharm 250 mg, tablettenBetapharm Arzneimittel GmbH
- PolandAbirateron AristoAristo Pharma Sp. z o.o.
- CzechiaABIRATERONE ABDIAbdi Farma GmbH, Heppenheim
- United KingdomAbiraterone 250mg tabletsCrescent Pharma Ltd
- FinlandAbirateron AvansorAvansor Pharma Oy
- IrelandAbiraterone Accord 250 mg tabletsAccord Healthcare S.L.U.
Authorised across Europe · EMA
The same active substance is authorised in 31 EEA countries. Names it is sold under:
- Austria · Abiral, Abirateron +pharma
- Belgium · Abirateron Eg, Abirateronacetaat Eg (Eurogenerics) Nv
- Bulgaria · Абиратерон Msn, Абиратерон Деватис
- Cyprus · Abiraterone Farmoz, Abiraterone Pharmazac
- Czechia · Abirateron Ashcure, Abirateron Pharmagen
- Germany · Abibam®, Abiranio
- Denmark · Abirateron "olpha", Abirateron "sandoz"
- Estonia · Abiraterone G.L. Pharma, Abiraterone Norameda
- Spain · Abiraterona Ashcure, Abiraterona Cipla
- Finland · Abirateron Avansor, Abirateron Devatis
- France · Abiraterone Acetate Zydus, Abiraterone Arrow
- United Kingdom (Northern Ireland) · Abiraterone, Abiraterone Abdi
- Greece · Abinone, Abiprostem
- Croatia · Abirateron Alpha-Medical, Abirateron Devatis
- Hungary · Abaxan, Abirateron Galenika
- Ireland · Abiraterone, Abiraterone Aristo
- Iceland · Abirateron, Abirateron Medical Valley
- Italy · Abiraterone Abdi, Abiraterone Abdi Farma
- Liechtenstein · Abiraterone Accord, Abiraterone Mylan
- Lithuania · Abiraterone G.L. Pharma, Abiraterone Norameda
- Luxembourg · Abirateron Eg, Abiraterone Eugia
- Latvia · Abiraterone G.L. Pharma, Abiraterone Norameda
- Malta · Abiraterone Ashcure, Abiraterone Clonmel
- Netherlands · Abirateron 1a Pharma, Abirateron Abdi
- Norway · Abirateron Devatis, Abirateron Medical Valley
- Poland · Abiral, Abirateron Sun
- Portugal · Abiraterona Bluepharma, Abiraterona Eugia
- Romania · Abirateron? Lannacher, Abirateronă
- Sweden · Abirateron Devatis, Abirateron Medical Valley
- Slovenia · Abirateron Galenika, Abirateron Teva
- Slovakia · Abirateron Msn, Abirateron Pharmagen
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4203947c-3ade-4e32-951f-96d7c6870d52 GET /v1/drugs/4203947c-3ade-4e32-951f-96d7c6870d52?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "250",
"substance": "ABIRATERONE ACETATE",
"productndc": "72789-213",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA208339",
"marketing_category": "ANDA"
}See everything about abiraterone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.